Clariant slumps on Q4 adj. core profit miss

** Shares in Clariant CLN fall nearly 11% as the Swiss speciality chemicals maker posted quarterly adjusted core earnings miss weighed down by the Care Chemicals segment

** It reported Q4 adj. EBITDA rising 1% year-on-year to CHF 160 million ($177.48 million), but missing the 181 million CHF seen in a company-provided poll

** "The Care Chemicals performance fell slightly short of our expectations due to lower seasonal aviation and refinery business," it said in a statement

** The company guiding to the lower end of the previously provided 3-5% local currency sales growth in 2025, with a ~3% FX headwind expected on top, suggests limited to no top-line growth in 2025, as per J.P. Morgan

** Due to significant restructuring costs in 2025, the reported EBITDA margin guidance for the year of 15%-15.5% implied reported EBITDA is ~18% below consensus, the broker adds

** The stock is on track for its worst day in 3 years

($1 = 0.9015 Swiss francs)